{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:14:33Z","timestamp":1776935673145,"version":"3.51.4"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T00:00:00Z","timestamp":1368144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063344","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T21:03:31Z","timestamp":1368219811000},"page":"e63344","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Julie","family":"Todoroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel M.","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Fillee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Jurion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Renauld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Huygen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Vanbever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,5,10]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2010) Tuberculosis - Fact sheet n\u00b0104."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0966-842X(00)88986-6","article-title":"BCG vaccination against tuberculosis: past disappointments and future hopes","volume":"3","author":"PW Roche","year":"1995","journal-title":"Trends Microbiol"},{"key":"ref3","unstructured":"World Health Organization (2006) The Stop TB Strategy."},{"key":"ref4","unstructured":"Stop TB Partnership (2009) Tuberculosis vaccine candidates."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/infdis\/jir195","article-title":"Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants","volume":"203","author":"TJ Scriba","year":"2011","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.mimet.2009.10.010","article-title":"The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis: development of a novel assay and quantification of glycolipid-status of the mycobacterial cell wall","volume":"79","author":"AA Elamin","year":"2009","journal-title":"J Microbiol Methods"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1517\/14712598.2012.721768","article-title":"An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time","volume":"12","author":"M Romano","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/14760584.6.2.213","article-title":"Pulmonary vaccine delivery","volume":"6","author":"D Lu","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nri2236","article-title":"Regulation of immunological homeostasis in the respiratory tract","volume":"8","author":"PG Holt","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2567.2007.02641.x","article-title":"The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response","volume":"122","author":"A Minne","year":"2007","journal-title":"Immunology"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Todoroff J, Ucakar B, Inglese M, Vandermarliere S, Fillee C, <etal>et al<\/etal>. (2012) Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery. European Journal of Pharmaceutics and Biopharmaceutics <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1016\/j.ejpb.2012.11.020\" xlink:type=\"simple\">10.1016\/j.ejpb.2012.11.020<\/ext-link><\/comment>.","DOI":"10.1016\/j.ejpb.2012.11.020"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0264-410X(99)00572-1","article-title":"Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration","volume":"18","author":"JR Baldridge","year":"2000","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.vetimm.2006.03.005","article-title":"B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination","volume":"112","author":"E Fingerut","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0264-410X(00)00249-8","article-title":"Immune effects and mechanisms of action of CpG motifs","volume":"19","author":"AM Krieg","year":"2000","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11274-009-0195-z","article-title":"Recombinant Escherichia coli heat-labile enterotoxin B subunit humoral adjuvant effect depends on dose and administration route","volume":"26","author":"G Fischer","year":"2010","journal-title":"World Journal of Microbiology and Biotechnology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"V Mata-Haro","year":"2007","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation","volume":"5","author":"AM Krieg","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2010.11.091","article-title":"Non-toxic derivatives of LT as potent adjuvants","volume":"29","author":"VP da Hora","year":"2010","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1517\/14712598.7.11.1731","article-title":"Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy","volume":"7","author":"M Barry","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"CR Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1128\/JVI.80.10.4962-4970.2006","article-title":"Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers","volume":"80","author":"I Stephenson","year":"2006","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2007.04.010","article-title":"Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A","volume":"111","author":"T Gartner","year":"2007","journal-title":"Immunol Lett"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.71.1.483-493.2003","article-title":"Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis","volume":"71","author":"S D\u2019Souza","year":"2003","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-2478(94)00188-W","article-title":"An adjuvant formulation based on N-acetylglucosaminyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with dimethyldioctadecylammonium chloride and zinc-L-proline complex as synergists","volume":"44","author":"N Grubhofer","year":"1995","journal-title":"Immunol Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.67.9.4586-4593.1999","article-title":"Assessment of immunity to mycobacterial infection with luciferase reporter constructs","volume":"67","author":"VA Snewin","year":"1999","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2567.2006.02373.x","article-title":"Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3","volume":"118","author":"M Romano","year":"2006","journal-title":"Immunology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.coi.2012.04.008","article-title":"Protection versus pathology in tuberculosis: recent insights","volume":"24","author":"AM Cooper","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000029329","article-title":"Pulmonary defence mechanisms","volume":"66","author":"LP Nicod","year":"1999","journal-title":"Respiration"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1183\/09031936.96.09081736","article-title":"Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation","volume":"9","author":"M Drent","year":"1996","journal-title":"Eur Respir J"},{"key":"ref30","first-page":"73","article-title":"The role of T-cell subsets in Mycobacterium tuberculosis infection","volume":"5","author":"WH Boom","year":"1996","journal-title":"Infect Agents Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2012.06.002","article-title":"New pathways of protective and pathological host defense to mycobacteria","volume":"20","author":"TH Ottenhoff","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174","author":"M Santosuosso","year":"2005","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.1101720","article-title":"Dual TCR expression biases lung inflammation in DO11.10 transgenic mice and promotes neutrophilia via microbiota-induced Th17 differentiation","volume":"187","author":"MM Lemaire","year":"2011","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"J Wang","year":"2004","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"NP Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1073\/pnas.0800043105","article-title":"Immunization by a bacterial aerosol","volume":"105","author":"L Garcia-Contreras","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"J Dietrich","year":"2006","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.4049\/jimmunol.181.8.5618","article-title":"Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung","volume":"181","author":"M Jeyanathan","year":"2008","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.178.4.2387","article-title":"Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization","volume":"178","author":"M Santosuosso","year":"2007","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4049\/jimmunol.176.5.3019","article-title":"Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2","volume":"176","author":"N Banaiee","year":"2006","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.micinf.2007.09.007","article-title":"Interactions of pathogenic mycobacteria with host macrophages","volume":"9","author":"V Sundaramurthy","year":"2007","journal-title":"Microbes Infect"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell\u2019s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"DJ Lewis","year":"2009","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T15:45:30Z","timestamp":1595778330000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063344"}},"subtitle":[],"editor":[{"given":"Anil Kumar","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,10]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063344","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,10]]}}}